Survey
Quarterly Survey: Continuous Glucose Monitoring Systems (CGM) and Insulin Pumps Usage Trends and Preferences January 2024
Ticker(s): SENS, TNDM, PODD, DXCM, ABT, MDTThe survey results include 20 Endocrinologists.
How many patients with diabetes are in your practice?
How many of your patients are eligible for a continuous glucose monitoring (CGM) device system?
How many patients started using a CGM device system for the first time in the last 30 days?
How many patients switched from one CGM device system to a new CGM in the last 30 days?
Why are patients switching devices, and which CGM device system are patients switching to?
How many patients do you anticipate will start using a CGM device system in the next 30 days?
How much do you anticipate the volume of CGM usage to increase, if at all, over the following?
- 1 year
- 3 years
- 5 years
What is the percentage breakdown of CGM system device brands you currently use?
- FreeStyle Libre
- Guardian Connect
- DexCom
- Eversense
- Other
What is the percentage breakdown of CGM system device brands you expect to use in 1 year?
- FreeStyle Libre
- Guardian Connect
- DexCom
- Eversense
- Other
Which of the following is your preferred CGM device?
- FreeStyle Libre
- Guardian Connect
- DexCom
- Eversense
- Other
In response to your answer above, why is this your preferred CGM device?
Are there any barriers at your practice/institution that restrict the CGM device you offer?
What features being added to future generation CGM devices would have you consider switching manufacturers or significantly shifting share?
What % of your patients on a CGM are also currently using an insulin pump?
What is the percentage breakdown of insulin pump brands you currently use?
- Medtronic MiniMed
- Omnipod Dash
- Omnipod 5
- Tandem t:slim X2
- Other
What is the percentage breakdown of insulin pump brands you expect to use in 1 year?
- Medtronic MiniMed
- Omnipod Dash
- Omnipod 5
- Tandem t:slim X2
- Other
Which of the following brands is your preferred insulin pump brand?
- Medtronic MiniMed
- Omnipod Dash
- Omnipod 5
- Tandem t:slim X2
- Other
In response to your answer above, why is this your preferred insulin pump brand?
How have recent insurance coverage changes impacted your brand recommendation?
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
